Bristol Myers Squibb Co. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Bristol Myers Squibb Co. (BMY) inched 0.44% higher to $66.00 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.15% to 3,855.76 and Dow Jones Industrial Average falling 0.28% to 31,819.14. The stock's rise snapped a five-day losing streak. Bristol Myers Squibb Co. closed $15.44 below its 52-week high ($81.44), which the company reached on December 1st.
The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson (JNJ) rose 0.96% to $153.06, Pfizer Inc. (PFE) rose 1.19% to $39.86, and Abbott Laboratories (ABT) rose 1.27% to $98.19. Trading volume (9.6 M) eclipsed its 50-day average volume of 7.9 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 13, 2023.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 13, 2023 16:42 ET (20:42 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.